GL1X · GenesisL1 explorer

MolNFT v1 · #184312 · protein

Mertk kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole group

7OLS: “Mertk kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole group”. X-ray diffraction, 2 ligands (VJZ, CL). MolNFT v1 #184312 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7OLS
Type
protein
Length
273 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q12866
Ligands
VJZ, CL

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein273—Q12866

Ligands and binding sites

  • VJZ · 5-[4-(1,5-dimethylpyrazol-4-yl)-2-methyl-phenyl]-~{N}-(imidazo[1,2-a]pyridin-6-ylmethyl)-~{N}-methyl-1,3,4-oxadiazol-2-amine · ligand · chains A
  • CL · Chloride ion · ion · 4 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7OLS · MerTK kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole group · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.